Studies, Senator Prompt FDA To Look At Chantix
Amid reports of numerous health problems linked to Pfizer's anti-smoking drug Chantix, the U.S. Food and Drug Administration is taking a close look at a new study and planning to meet...To view the full article, register now.
Already a subscriber? Click here to view full article